期刊文献+

扩散加权成像对前列腺外周带癌的诊断 被引量:4

Value of diffusion-weighted imaging in the diagnosis of prostate carcinoma
下载PDF
导出
摘要 目的探讨扩散加权成像(DWI)在前列腺外周带癌诊断中的价值。方法分别对21例前列腺癌患者、28例前列腺增生(BPH)患者和15名健康志愿者进行前列腺DWI扫描,分析三者的DWI图、表观扩散系数(ADC)图的信号表现,测量癌灶、前列腺增生、正常前列腺外周带的ADC值。所有前列腺癌及前列腺增生病例均以手术或穿刺活检病理诊断为标准。结果 DWI上前列腺癌灶表现为高信号影,前列腺增生结节呈稍高信号且信号较混杂,正常前列腺外周带呈稍低信号。前列腺癌灶平均ADC值0.98×10^(-3)mm^2/s,前列腺增生结节平均ADC值1.32×10^(-3)mm^2/s;志愿者前列腺外周带平均ADC值2.14×10^(-3)mm^2/s。结论前列腺癌灶、前列腺增生结节、正常前列腺外周带在DWI图像上信号有较大差别,前列腺癌灶信号较高。前列腺癌灶的ADC值低于正常前列腺外周带及前列腺增生结节。DWI是诊断前列腺外周带癌的依据之一。 Objective To explore the diagnostic value of diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) in prostate carcinoma (PCa). Methods Forty-nine patients with histologically confirmed PCa (21) or benign prostatic hyperplasia (BPH, 28) and 15 healthy volunteers underwent DWI. The DWI and ADC characteristics were analyzed. Results PCa showed very high signal intensity on DWI. The signal intensity of BPH was more heterogeneous and lower than whereas the signal intensity of normal peripheral zone was even lower and homogeneous. The mean ADC values of PCa, BPH and normal peripheral zone were 0.98 x 10-3mm2/s, 1.32 x 10-3mm2/s and 2.14 x 10-3mm2/s, respectively. Conclusions PCa has very high DWI signal intensity with significantly lower ADC values than BPH and normal oerioheral zone allowin~ diagnosis of carcinoma.
出处 《影像诊断与介入放射学》 2013年第6期423-425,共3页 Diagnostic Imaging & Interventional Radiology
关键词 前列腺肿瘤 扩散加权成像 诊断 Prostate carcinoma Diffusion-weighted imaging Diagnosis
  • 相关文献

参考文献12

  • 1Parkin DM,Bray F,Ferlay J. Global cancer statistics[J].{H}CA-A Cancer Journal for Clinicians,2007.74-108.
  • 2Chen S,Ikawa F,Kurisu K. Quantitative MR evaluation of intracranial epidermoid tumors by fast fluid-attenuated inversion recovery imaging and echo-planar diffusion-weighted imaging[J].AJNPR,2001.1089-1096.
  • 3Kitajima K,Kaji Y,Kuroda K. High b-value diffusion-weig-hted imaging in normal and malignant peripheral zone tissue of the prostate:effect of signal-to-noise ratio[J].Magn Reson Med Sci,2008.93-99.
  • 4李春媚,陈敏,李飒英,王文超,赵伟峰,杨正汉,刘明,周诚.前列腺癌的MRI诊断:T2WI、DWI、MRS及其综合应用[J].磁共振成像,2010,1(4):257-263. 被引量:41
  • 5Gibbs P,Pickles MD,Turnbull LW. Diffusion imaging of the prostate at 3.0 tesla[J].{H}Investigative Radiology,2006.185-188.
  • 6Miao H,Fukatsu H,Ishigaki T. Prostate cancer detection with 3.0-T MRI:comparison of diffusion-weighted and T2-weighted imaging[J].{H}EUROPEAN JOURNAL OF RADIOLOGY,2007.297-302.
  • 7Pickles MD,Gibbs P,Sreenivas M. Diffusion-weighted ima-ging of normal and malignant prostate tissue at 3 0T[J].J Magn Reson Imaging,2006.130-134.
  • 8王丽娟,袁曙光,闫东,王家平,郝金钢,郭立,刘灿丽.前列腺癌的磁共振DWI诊断价值[J].放射学实践,2009,24(6):661-663. 被引量:22
  • 9Yoshimitsu K,Kiyoshima K,Irie H. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma:correlation with stepwise histopathology[J].{H}Journal of Magnetic Resonance Imaging,2008.132-139.
  • 10Grossfeld GD,Coakley FV. Benign prostatic hyperplasia:clinical overview and value of diagnostic imaging[J].{H}Radiologic Clinics of North America,2000.31-47.

二级参考文献45

  • 1王霄英,周良平,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.RS对中国人前列腺癌鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153. 被引量:97
  • 2王霄英,丁建平,周良平,李飞宇,范晓颖,王继琛,蒋学祥.前列腺癌的MR扩散成像初步研究[J].中华放射学杂志,2005,39(11):1207-1209. 被引量:68
  • 3许东,王志军,全勇.磁共振扩散加权成像对前列腺癌的诊断价值[J].放射学实践,2006,21(12):1240-1242. 被引量:8
  • 4Marier CF,Paran Y,Bendel P,et al.Quantitative Diffusion Imaging in Implanted Human Breast Tumors[J].Magn Reson Med,1997,37(4):576-581.
  • 5Sakuma H,Nomura Y,Takeda K,et al.Adult and Neonatal Human Brain Diffusional Anisotropy and Myelination with Diffusion-weighted MR Imaging[J].Radiology,1991,180(2):229-233.
  • 6Hosseinzadeh K,Schwarz SD.Endorectal Diffusion-weighted Imaging in Prostate Cancer to Differentiate Malignant and Benign Peripheral Zone Tissue[J].J Magn Reson Imaging,2004,20(5):654-661.
  • 7Desprechins B,Stadnik T,Koerts G,et al.Use of Diffusion Weighted MR Imaging in Differential Diagnosis between Intracerebral Necrotic Tumors and Cerebral Abscesses[J].AJNR,1999,20(10):1252-1257.
  • 8National Cancer Institute (NCI).The prostate-specific antigen (PSA) test:Questions and answers[EB/OL].[2006-09-01].http://www.cancer.gov/cancertopics/factsheet/Detection/ PSA.
  • 9Federal Food and Drug Administration.FDA Approves Test for Prostate Cancer[EB/OL].[2009-10-25].http://www.scienceblog.com/community/older/archives/M/1/fda0245.htm.
  • 10Nielsen ME,Partin AW.The role of complexed prostate-specific antigen in prostate cancer screening.In:Jones JS,ed.Prostate biopsy:indications,techniques,and complications.Totowa,NJ:Humana Press Inc,2008:14-24.

共引文献64

同被引文献19

引证文献4

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部